Download PDF

Other users also viewed these articles

Prevalence of metabolic associated fatty liver disease (MAFLD) in patients with gallstone disease. Study on a cohort of cases in South-Southeastern Mexico F. Roesch-Dietlen; A.G. Pérez-Morales; P. Grube-Pagola; M. González-Santes; F. Díaz-Roesch; A. Triana-Romero; L. Roesch-Ramos; J.M. Remes-Troche; M. Cruz-Aguilar;
Rev Gastroenterol Mex. 2023;88:225-31
Pharmacologic treatment of irritable bowel syndrome. Position statement of the Asociación Mexicana de Gastroenterología, 2024 J.M. Remes-Troche; E. Coss-Adame; M. Schmulson; K.R. García-Zermeño; M. Amieva-Balmori; R. Carmona-Sánchez; O. Gómez-Escudero; P.C. Gómez-Castaños; M.E. Icaza-Chávez; A. López-Colombo; E.C. Morel-Cerda; M.Á. Valdovinos-Díaz; L.R. Valdovinos-García; A.S. Villar-Chávez;
10.1016/j.rgmxen.2024.10.009
Good clinical practice recommendations for proton pump inhibitor prescription and deprescription. A review by experts from the AMG L.R. Valdovinos-García; A.S. Villar-Chávez; F.M Huerta-Iga; M. Amieva-Balmori; J.S. Arenas-Martínez; R. Bernal-Reyes; E. Coss-Adame; O. Gómez-Escudero; P.C. Gómez-Castaños; M. González-Martínez; E.C Morel-Cerda; J.M. Remes-Troche; M.C. Rodríguez-Leal; D. Ruiz-Romero; M.A. Valdovinos-Diaz; G. Vázquez-Elizondo; J.A. Velarde-Ruiz Velasco; M.R. Zavala-Solares;
10.1016/j.rgmxen.2024.11.002